ADHD Medication in Northern Ireland: Prescription Process, Costs and GP Shared Care

1. Introduction: A Clinical and Regulatory Analysis of Adult Treatment Pathways in Northern Ireland

Adults in Northern Ireland seeking private ADHD medication in Northern Ireland face a wait of more than three years through the Health and Social Care system. Private Consultant Psychiatrist-led medication management is available without a GP referral, with clinical appointments and treatment initiation typically occurring within seven days. Private Prescriptions issued by an appropriately registered Independent Prescriber can be dispensed at any registered UK pharmacy across Northern Ireland, offering a critical alternative for patients who require immediate clinical support.

The clinical and regulatory landscape governing ADHD pharmacotherapy in Northern Ireland is distinct from both the National Health Service in Great Britain and the Health Service Executive system in the Republic of Ireland. Stimulant medications are tightly controlled under UK Schedule 2 legislation, prescribing protocols vary between the five regional Health and Social Care Trusts, and shared care arrangements with general practitioners are entirely discretionary rather than guaranteed.

This guide examines the public waiting environment, the rules governing private and shared care prescribing, the medications licensed for adult ADHD in Northern Ireland, the costs involved, and the key practical differences between Northern Ireland and the Republic of Ireland for patients living near the border.

2. How Long Is the Wait for ADHD Medication Through the HSC in Northern Ireland?

The public healthcare landscape in Northern Ireland is currently defined by an extreme disparity between the growing demand for neurodevelopmental evaluations and the available capacity within the health service. For adults seeking attention deficit hyperactivity disorder assessment and subsequent medication, the waiting lists within the Health and Social Care system exceed three years across almost all regional Trust areas.

A critical clinical reality is that pharmacological treatment cannot be legally or safely initiated until after a formal diagnostic assessment has been completed and a diagnosis confirmed. Consequently, the total journey from the primary care referral to a stable, optimised medication regimen can span several years in the worst affected areas.

This systemic backlog is rooted in historical funding and structural decisions. While the National Institute for Health and Care Excellence estimates adult ADHD prevalence at between three and four percent, Northern Ireland has historically lacked a formal, regionally commissioned adult service pathway. Services have instead developed organically, relying on the local reconfiguration of existing mental health teams that are ill equipped to handle the modern influx of referrals.

A Freedom of Information request in 2023 revealed that the Belfast Health and Social Care Trust completed approximately 101 adult assessments in a year while the waiting list stood at 1,710 adults, producing a projected wait of close to seventeen years at the then current throughput. Across other regional Trusts, the longest individual wait recorded for an adult assessment has reached eight years.

For adults entering the system for the first time, the lack of dedicated regional funding means they must endure prolonged waits before accessing clinical support.

3. Can a GP Prescribe ADHD Medication in Northern Ireland Without a Specialist?

In Northern Ireland, ADHD medication should only be initiated following assessment and diagnosis by a specialist with expertise in ADHD, as part of a comprehensive treatment plan. This designation means that general practitioners are clinically prohibited from initiating ADHD medications without a formal diagnosis and a specific initiation protocol established by a recognised specialist.

Once a specialist has completed the diagnostic process, initiated the medication, and carefully titrated the dose until the patient is clinically stable, some general practitioners will agree to enter into a shared care arrangement. Under this framework, the GP assumes responsibility for issuing repeat prescriptions while the specialist clinic retains ultimate clinical oversight and performs the required periodic reviews.

Whether a GP will enter into such an agreement is entirely dependent on individual practice policies and the guidelines established by the local HSC Trust. General practitioners are under no contractual obligation to accept shared care requests. Where a GP declines, the prescribing responsibility does not transfer, and the patient must continue to obtain private prescriptions from their specialist to maintain treatment continuity.

4. How Does GP Shared Care for ADHD Work in Northern Ireland?

The formal protocol of GP shared care is a collaborative agreement designed to safely manage long-term attention deficit hyperactivity disorder prescribing within primary care. Under this framework, prescribing responsibility is gradually transferred to the general practitioner once a patient is established on a stable medication regimen, while the specialist clinic retains ultimate clinical oversight and conducts annual reviews.

In Northern Ireland, because there is no single standardised protocol across the region, shared care arrangements are governed by guidelines developed at the individual HSC Trust level. A shared care request that is accepted in the Belfast Trust may be declined in the Western Trust, creating significant regional variation in patient experience.

For a GP to consider a shared care arrangement, several criteria typically apply:

• The patient must possess a formal, documented diagnosis from a recognised and qualified specialist.
• The specialist must provide detailed titration records showing that the patient is on a stable dose with proven tolerability and minimal side effects.
• The specialist must send a formal, written shared care request outlining the clinical history, the precise medication regimen, and the protocol for ongoing monitoring.

ADHD Now provides all of the clinical documentation needed to support these primary care discussions, including detailed correspondence, weight and blood pressure tracking, and a comprehensive prescription history. If a general practitioner declines to participate in a shared care arrangement, the patient continues to receive private prescriptions and clinical reviews directly through the specialist pathway.

5. What ADHD Medications Are Available in Northern Ireland?

Pharmacotherapy for adult ADHD in Northern Ireland is categorised into stimulants, which are tightly regulated as Schedule 2 controlled drugs under UK legislation, and non-stimulants, which are not controlled substances. All available treatments are aligned with the clinical evidence guidelines published by the National Institute for Health and Care Excellence.

5.1 Stimulant Medications

Stimulants are governed in Northern Ireland by UK Schedule 2 of the Misuse of Drugs Regulations 2001 and include:

• Methylphenidate and lisdexamfetamine. Both lisdexamfetamine and methylphenidate are NICE-recommended first-line pharmacological treatments for adults with ADHD. Methylphenidate is marketed under brand names including Ritalin, Concerta XL, Equasym XL, and Medikinet. Lisdexamfetamine is branded in Northern Ireland and the rest of the United Kingdom as Elvanse. It is clinically vital to note that this exact active substance is branded as Elvanse in the United Kingdom whereas it is marketed as Tyvense in the Republic of Ireland.
• Dexamfetamine — licensed and available, though less commonly prescribed as a primary option.

5.2 Non-Stimulant Medications

Non-stimulants are not controlled drugs and can be issued on a standard private prescription:

• Atomoxetine — branded as Strattera, an alternative for patients who do not tolerate stimulants or have coexisting medical conditions that contraindicate stimulant use.
• Guanfacine — branded as Intuniv, frequently utilised to address symptoms of emotional dysregulation, including rejection sensitivity.

Selection of a specific medication is determined by an Independent Prescriber following a comprehensive assessment of the patient’s symptom profile, cardiovascular history, and lifestyle needs.

6. How Does a Private ADHD Prescription Work in Northern Ireland?

The private prescription process operates under rigorous statutory controls to ensure clinical safety and legal compliance. The pathway follows a structured sequence:

• Clinical evaluation: An Independent Prescriber from the Consultant Psychiatrist-led team conducts a comprehensive clinical evaluation to establish the diagnostic basis and determine the clinical rationale for initiating medication.
• Prescription generation: For stimulant medications such as methylphenidate and lisdexamfetamine, the prescription must comply with UK Schedule 2 controlled drug regulations. It must be handwritten or computer-generated on a PCD1 script pad, with a wet ink signature, and remains valid for exactly twenty-eight days from the date of signing.
• Required prescription details: A private prescription for a Schedule 2 controlled drug must explicitly state the patient’s full name, address, date of issue, drug name, formulation, strength, and total quantity in both words and figures, alongside the prescriber’s signature.
• Dispensing: The patient takes the physical prescription to any registered UK pharmacy operating in Northern Ireland, including national providers such as Boots, Lloyds Pharmacy, and Well Pharmacy, alongside independent local chemists.
• Dispensing fee: The pharmacist dispenses the medication and charges a private dispensing fee, which typically ranges from £30 to £90 per month depending on the specific molecule, formulation, and dosage.
• Monitoring data: As part of the ADHD Now and Duality Healthcare clinical pathway, the patient gathers and presents routine monitoring data — including blood pressure, heart rate, weight, and sleep quality — at each subsequent review appointment.
• Re-issuance: Prescriptions are reissued at each clinical review during the titration phase and as required after the patient achieves clinical stabilisation.

For patients seeking further details on the collection process, the frequently asked questions about ADHD care in Northern Ireland resource provides comprehensive guidance.

From a practical perspective, controlled drug stock levels can fluctuate significantly across pharmacies. It is highly recommended that patients contact their chosen pharmacy in advance to confirm that the specific formulation and strength are in stock before attempting to fill a new private prescription.

7. How Much Does ADHD Medication Cost in Northern Ireland?

Navigating the financial aspects of private care in Northern Ireland requires a clear understanding of three distinct cost components: clinical service fees, pharmacy medication fees, and any ongoing membership or shared care arrangements.

7.1 Clinical Service Fees

The specialist pathway is structured around the following fees:

• Intake consultation: £49, which confirms the diagnostic foundation and initiates the pathway.
• Initiation and titration: £289 per month for a typical duration of three months, covering monthly reviews by an Independent Prescriber from the Consultant Psychiatrist-led team and prescription issuance by Duality Healthcare.
• Routine follow-up reviews: £125 per appointment after clinical stabilisation, conducted as clinically required.
• Ongoing membership via Duality Healthcare: £49.99 per month to maintain prescription continuity and clinical monitoring after stabilisation.

A comprehensive breakdown of all diagnostic and prescribing fees is detailed on the ADHD medication costs in Northern Ireland reference page.

7.2 Pharmacy Costs

Pharmacy costs represent the actual price of the medication charged by the dispensing chemist and are entirely separate from clinical fees. Because these are private prescriptions, patients pay the private dispensing rate set by the pharmacy.

7.3 After Shared Care Is Established

If a general practitioner accepts a shared care agreement, they assume the prescribing role. Health and Social Care prescriptions in Northern Ireland are currently free of charge to NI residents, removing the dispensing cost component. However, many general practitioners will refuse to issue HSC prescriptions for ADHD medications initiated privately unless the patient has also been evaluated and diagnosed within the HSC system itself, so shared care should not be treated as a guaranteed onward route.sed within the HSC system itself, so shared care should not be treated as a guaranteed onward route.

8. Can I Transfer My Private ADHD Care to the HSC in Northern Ireland?

A common misconception is that obtaining a private diagnosis and initiating treatment will accelerate a patient’s position on the public HSC waiting list or grant them faster access to NHS services. In reality, the private and public pathways operate entirely independently; a private diagnosis does not queue a patient for HSC services.

Some general practitioners within the HSC may accept a private specialist’s diagnostic report and treatment records as the basis for entering into a shared care agreement. However, this transition is entirely at the discretion of the individual GP. ADHD Now provides detailed clinical correspondence, monitoring records, and formal documentation specifically structured to support these shared care discussions with primary care physicians.

For most patients in Northern Ireland, the most reliable and consistent ongoing route is to maintain private prescription management or transition to an ongoing Duality Healthcare membership structure after achieving clinical stability on medication.

9. Do I Need a GP Referral for Private ADHD Medication in Northern Ireland?

No GP referral is required at any stage of the private pathway. Adults in Northern Ireland can refer themselves directly to begin their clinical journey. With explicit patient consent, documentation and clinical summaries are shared with the patient’s general practitioner to ensure that the wider primary care team remains fully informed and care is coordinated safely.

For individuals who already possess a formal ADHD diagnosis from another registered provider, the pathway allows them to access medication management directly through the initial intake consultation without a repeat assessment.

Individuals who have not yet received a formal diagnosis can arrange an ADHD assessment in Northern Ireland to establish a clinical foundation before progressing to medication management.

10. What Happens at the Private ADHD Medication Intake in Northern Ireland?

The private medication intake is a structured clinical process conducted online via a secure thirty-minute video consultation with an Independent Prescriber from the Consultant Psychiatrist-led team. During the appointment, the Independent Prescriber conducts a detailed review of the patient’s existing diagnostic records, medical history, and current symptoms.

A primary focus of the intake is to establish baseline cardiovascular safety. The clinician reviews recent blood pressure and heart rate measurements alongside a comprehensive review of any family history of cardiac conditions. The Independent Prescriber also conducts a thorough mental health screening to assess concurrent conditions, specifically evaluating current levels of anxiety, mood disturbance, and sleep quality.

Following this assessment, a collaborative clinical decision is reached regarding whether structured medication initiation and titration are safe and appropriate. If medication is deemed clinically unsuitable, the pathway ceases at this stage and the patient is provided with a comprehensive written clinical summary explaining the reasoning.

The clinical pathway does not employ the QB Test or the CAARS in the adult assessment process. Instead, clinicians utilise validated diagnostic instruments — specifically the WEISS Symptom Record (WRS II), the Wender Utah Rating Scale (WURS-25), and the Adult ADHD Self-Report Scale v1.1 (ASRS).

ADHD Medication in Northern Ireland vs Republic of Ireland: Key Differences

For individuals residing near the border, navigating the clinical and regulatory differences between the two jurisdictions is essential. Northern Ireland operates under the Health and Social Care system using British Pound Sterling, whereas the Republic of Ireland operates under the Health Service Executive using the Euro.

The regulatory licensing and drug scheduling also differ significantly. Stimulant medications in Northern Ireland are governed by UK Schedule 2 controlled drug regulations, which restrict prescription validity to exactly twenty-eight days. In contrast, the Republic of Ireland operates under Irish Misuse of Drugs Regulations, where stimulant prescriptions can remain valid for up to three months.

The primary stimulant brand names also differ. Lisdexamfetamine is branded as Elvanse in Northern Ireland and across Great Britain, while it is marketed as Tyvense in the Republic of Ireland. These differences require careful coordination, as prescriptions written by clinicians in one jurisdiction cannot be directly dispensed across the border.

To explore medication management options and begin your clinical pathway, please visit the private ADHD medication in Northern Ireland resource page.

12. Conclusion: Removing the Wait

Adults in Northern Ireland seeking pharmacological treatment for ADHD face a structural public healthcare backlog that, in the worst-affected Trust areas, can stretch the journey from referral to stable medication across four to five years. A regulated private pathway, anchored in Consultant Psychiatrist oversight and dispensable at any registered UK pharmacy, is the most reliable way to compress that timeline to weeks rather than years.

The £49 intake confirms the diagnostic foundation, the three-month titration phase establishes a stable, monitored regimen, and the optional Duality Healthcare membership preserves prescription continuity. Where a GP elects to enter a shared care arrangement, ADHD Now supplies the clinical correspondence needed; where they decline, the private pathway remains a complete and self-sufficient route.

Works Cited

1. National Institute for Health and Care Excellence. (2018, updated 2019). Attention deficit hyperactivity disorder: diagnosis and management (NG87). [LINK]
2. Royal College of Psychiatrists. (2024). ADHD in Adults. [LINK]
3. Government of the United Kingdom. (2001). The Misuse of Drugs Regulations 2001 — Schedule 2. [LINK]
4. Northern Ireland Assembly Research and Information Service. (2024). Briefing Paper: Adult ADHD Services in Northern Ireland. [LINK]
5. Belfast Health and Social Care Trust. (2024). ADHD Information — Community Paediatrics. [LINK]
6. Northern Health and Social Care Trust. (2025). Waiting Times. [LINK]
7. Community Pharmacy England. (2024). Dispensing Controlled Drugs. [LINK]
8. ADHD UK. (2024). Belfast Health and Social Care Trust ADHD Assessment Information. [LINK]
9. Health Service Executive National Clinical Programme for ADHD in Adults & ADHD Ireland. (2025). Adult ADHD in Ireland. [LINK]
10. Government of Ireland. (2024). Misuse of Drugs (Amendment) Regulations 2024 (S.I. No. 71/2024). [LINK]